U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07937046) titled 'Single and Multiple Ascending Dose Study of KRP-203 in Healthy Japanese Adults' on Oct. 07.
Brief Summary: KRP-203 is an experimental medicine taken as a capsule. It keeps some white blood cells (lymphocytes) inside the lymph nodes, so fewer circulate in the blood. It may help treat diseases where the immune system attacks the body, such as ulcerative colitis. After earlier studies in the United Kingdom, this study tested KRP-203 for the first time in healthy Japanese adults.
What did the study want to find out?
The main goal was to learn how safe and well tolerated KRP-203 is after one dose and after daily doses for 28 days. It a...